The Beauty Health Company (SKIN) Q4 2023 Earnings Call Transcript

Mar. 12, 2024 10:56 PM ETThe Beauty Health Company (SKIN) StockSKIN
SA Transcripts
153.96K Followers

Q4: 2024-03-12 Earnings Summary

EPS of $0.01 beats by $0.08
 | Revenue of $96.80M (-1.36% Y/Y) beats by $9.19M

The Beauty Health Company (NASDAQ:SKIN) Q4 2023 Earnings Conference Call March 12, 2024 4:30 PM ET

Company Participants

Norberto Aja - Investor Relations
Marla Beck - Chief Executive Officer
Michael Monahan - Chief Financial Officer

Conference Call Participants

Olivia Tong - Raymond James
Oliver Chen - TD Cowen
Allen Gong - JPMorgan
Alec Legg - Canaccord Genuity
Jon Block - Stifel
Korinne Wolfmeyer - Piper Sandler
Ashley Helgans - Jefferies

Operator

Good afternoon and welcome to The Beauty Health Company's Fourth Quarter and Full Year 2023 Conference Call. [Operator Instructions] Please also note this event is being recorded.

And I'd like to turn the floor over to Norberto Aja, Investor Relations. Please go ahead.

Norberto Aja

Thank you, operator and good afternoon, everyone. Thank you for joining us today to discuss The Beauty Health Company's fourth quarter and full year 2023 financial results which were released earlier this afternoon and can be found on our website at beautyhealth.com. Joining us on the call today are BeautyHealth's Chief Executive Officer, Marla Beck; along with Chief Financial Officer, Mike Monahan.

Before we begin, I would like to remind you of the company's Safe Harbor language. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. Listeners are cautioned not to place undue reliance on any forward-looking statements. For a further discussion of risks related to our business, please see the company's filings with the SEC. This call will present non-GAAP financial measures. Reconciliation of these non-GAAP financial measures to the most comparable GAAP measures are in the earnings press release furnished to the SEC and available on our website. Following management's prepared remarks, we will open the call for a question-and-answer session.

With

Recommended For You

About SKIN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on SKIN